Innovative patented dry fermentation technology for cost-effective and highly nutritious production of hybrid mycelium-plant meat analogues
The MEATLOW project aims to optimize a novel mycelium-plant fermentation technology to produce healthy, eco-friendly meat analogues for the EU market by 2026.
Projectdetails
Introduction
In a public enquiry made by the European Commission, 80% of respondents were willing to reduce their meat intake to help reduce the emission of greenhouse gases (GHG), and 74% intended to change their diet to improve their health.
Current Issues with Meat Analogues
However, current meat analogues in the market are not a healthy alternative, since they are ultra-processed, full of binders and additives. Among their ingredients, we can find high amounts of sugars and sodium, maltodextrins, or soy isolate, which are not indicated for a healthy diet.
Environmental Concerns
In addition, these products are not ecological, as they are highly resource-demanding, mainly in terms of:
- Water consumption
- Wastewater generation
- Energy use
They also cause significant GHG emissions. On top of that, the existing meat analogues are rejected by consumers due to their off-taste and bad texture that do not resemble meat.
Millow's Innovative Solution
In response to this situation, Millow has developed to TRL6 a novel solid-state dry fermentation production technology for mycelium-plant meat analogues.
Advantages of the New Technology
This highly scalable and cost-effective innovative process accelerates mycelium growth from the typical 3-7 days periods to less than 24 hours. The benefits of this technology include:
- Reducing required water input by 97%
- Reducing energy use requirements by 67%
- Reducing CO2 footprint by 95% compared to benchmark methods based on liquid fermentation
The resulting products have a neutral taste and a pleasant texture that mimics meat attributes without the use of artificial binders. They are minimally processed, healthy, nutritional, and eco-friendly.
Project Goals
In the MEATLOW project, we aim to optimise and automate our innovative technology to reach TRL8 and commercial status. Our goal is to introduce our disruptive plant-fungi products in the EU meat substitute market by 2026.
Team Commitment
To achieve this, our highly skilled team of scientific, management, and marketing professionals is determined to lead this project to success.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.441.250 |
Totale projectbegroting | € 3.487.500 |
Tijdlijn
Startdatum | 1-7-2024 |
Einddatum | 30-6-2026 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- MILLOW ABpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat ApplicationsProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients. | EIC Transition | € 2.432.030 | 2024 | Details |
Technische en Economische haalbaarheid van Mycelium voorkweek in de productie van Mycoproteïnes op reststromen.Het project onderzoekt de haalbaarheid van een voorkweekproces om de fermentatieduur van mycoproteïnes uit reststromen met 30% te verkorten, gericht op de vlees- en visvervangende industrie. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
Productie van nieuwe vleesvervangers op basis van microbieel eiwitDalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid. | MIT R&D Samenwerking | € 113.663 | 2018 | Details |
Kweekvlees op boerderijschaalDit project valideert het ontwerp en verdienmodel van lokaal geproduceerde kweekvlees op boerderijschaal voor duurzame voedselproductie. | KvW3 - geavanceerde technologieën | € 238.956 | 2022 | Details |
A Revolutionary Tech for Exceptionally Efficient Natural Muscle Tissue Growth in Cultivated Meat Applications
ProFuse aims to optimize a novel myoblast cell line and media supplement to enhance the scalability and quality of cultivated meat, targeting TRL6 validation with potential clients.
Technische en Economische haalbaarheid van Mycelium voorkweek in de productie van Mycoproteïnes op reststromen.
Het project onderzoekt de haalbaarheid van een voorkweekproces om de fermentatieduur van mycoproteïnes uit reststromen met 30% te verkorten, gericht op de vlees- en visvervangende industrie.
Productie van nieuwe vleesvervangers op basis van microbieel eiwit
Dalco Food en BioscienZ ontwikkelen een technologie voor de grootschalige productie van microbiële eiwitten uit groente- en fruitreststromen, gericht op efficiënte vleesvervangers en voedselveiligheid.
Kweekvlees op boerderijschaal
Dit project valideert het ontwerp en verdienmodel van lokaal geproduceerde kweekvlees op boerderijschaal voor duurzame voedselproductie.